We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 61-80 of 2,432 results
  1. Aminochrome Induces Neuroinflammation and Dopaminergic Neuronal Loss: A New Preclinical Model to Find Anti-inflammatory and Neuroprotective Drugs for Parkinson’s Disease

    Abstract

    Studies have suggested aminochrome as an endogenous neurotoxin responsible for the dopaminergic neuron degeneration in Parkinson’s disease...

    Fillipe Mendes De Araújo, Annyta Fernandes Frota, ... Victor Diógenes Amaral Silva in Cellular and Molecular Neurobiology
    Article 06 January 2022
  2. Impact of Sleep Deprivation on Major Neuroinflammatory Signal Transduction Pathways

    Sleep deprivation (SD) is emulating an epidemic imparting detrimental effects ranging from immediate repercussions like vehicle accidents to very...

    Arehally M. Mahalakshmi, Prithvi Lokesh, ... Saravana Babu Chidambaram in Sleep and Vigilance
    Article 20 May 2022
  3. Interleukin-1 blockade attenuates white matter inflammation and oligodendrocyte loss after progressive systemic lipopolysaccharide exposure in near-term fetal sheep

    Background

    Increased systemic and tissue levels of interleukin (IL)-1β are associated with greater risk of impaired neurodevelopment after birth. In...

    Sharmony B. Kelly, Vanesa Stojanovska, ... Robert Galinsky in Journal of Neuroinflammation
    Article Open access 31 August 2021
  4. Partial Ablation of Astrocytes Exacerbates Cerebral Infiltration of Monocytes and Neuronal Loss After Brain Stab Injury in Mice

    In traumatic brain injury (TBI), mechanical injury results in instantaneous tissue damages accompanied by subsequent pro-inflammatory cascades...

    **a Hu, Shaojian Li, ... Yamei Tang in Cellular and Molecular Neurobiology
    Article 18 April 2022
  5. Progesterone and Allopregnanolone Neuroprotective Effects in the Wobbler Mouse Model of Amyotrophic Lateral Sclerosis

    Progesterone regulates a number of processes in neurons and glial cells not directly involved in reproduction or sex behavior. Several...

    Alejandro F. De Nicola, María Meyer, ... Maria Claudia Gonzalez Deniselle in Cellular and Molecular Neurobiology
    Article 17 June 2021
  6. Brain-wide Cas9-mediated cleavage of a gene causing familial Alzheimer’s disease alleviates amyloid-related pathologies in mice

    The pathology of familial Alzheimer’s disease, which is caused by dominant mutations in the gene that encodes amyloid-beta precursor protein (APP)...

    Yangyang Duan, Tao Ye, ... Nancy Y. Ip in Nature Biomedical Engineering
    Article 26 July 2021
  7. Aging exacerbates the brain inflammatory micro-environment contributing to α-synuclein pathology and functional deficits in a mouse model of DLB/PD

    Background

    Although ɑ-synuclein (ɑ-syn) spreading in age-related neurodegenerative diseases such as Parkinson’s disease (PD) and Dementia with Lewy...

    Michiyo Iba, Ross A. McDevitt, ... Eliezer Masliah in Molecular Neurodegeneration
    Article Open access 05 September 2022
  8. AAV-Mediated Artificial miRNA Reduces Pathogenic Polyglucosan Bodies and Neuroinflammation in Adult Polyglucosan Body and Lafora Disease Mouse Models

    Adult polyglucosan body disease (APBD) and Lafora disease (LD) are autosomal recessive glycogen storage neurological disorders. APBD is caused by...

    Emrah Gumusgoz, Sahba Kasiri, ... Berge A. Minassian in Neurotherapeutics
    Article Open access 28 March 2022
  9. E2F4-Based Gene Therapy Mitigates the Phenotype of the Alzheimer’s Disease Mouse Model 5xFAD

    After decades of unfruitful work, no effective therapies are available for Alzheimer’s disease (AD), likely due to its complex etiology that requires...

    Noelia López-Sánchez, Alberto Garrido-García, ... José M. Frade in Neurotherapeutics
    Article Open access 01 October 2021
  10. Repurposing Pomalidomide as a Neuroprotective Drug: Efficacy in an Alpha-Synuclein-Based Model of Parkinson’s Disease

    Marketed drugs for Parkinson’s disease (PD) treat disease motor symptoms but are ineffective in stop** or slowing disease progression. In the quest...

    Maria Francesca Palmas, Anna Ena, ... Anna R. Carta in Neurotherapeutics
    Article Open access 24 January 2022
  11. Microbial pathogens induce neurodegeneration in Alzheimer’s disease mice: protection by microglial regulation

    Background

    Neurodegeneration is considered the consequence of misfolded proteins’ deposition. Little is known about external environmental effects on...

    Tal Ganz, Nina Fainstein, ... Tamir Ben-Hur in Journal of Neuroinflammation
    Article Open access 06 January 2022
  12. Neuronal transcriptome, tau and synapse loss in Alzheimer’s knock-in mice require prion protein

    Background

    Progression of Alzheimer’s disease leads to synapse loss, neural network dysfunction and cognitive failure. Accumulation of protein...

    Austin Stoner, Li Fu, ... Stephen M. Strittmatter in Alzheimer's Research & Therapy
    Article Open access 15 November 2023
  13. Altered dynamics of glymphatic flow in a mature-onset Tet-off APP mouse model of amyloidosis

    Background

    Alzheimer’s disease (AD) is an incurable neurodegenerative disorder characterised by the progressive buildup of toxic amyloid-beta (Aβ) and...

    Inès R. H. Ben-Nejma, Aneta J. Keliris, ... Georgios A. Keliris in Alzheimer's Research & Therapy
    Article Open access 28 January 2023
  14. Tau antibody isotype induces differential effects following passive immunisation of tau transgenic mice

    One of the main pathological hallmarks of Alzheimer’s disease (AD) is the intraneuronal accumulation of hyperphosphorylated tau. Passive...

    Rinie Bajracharya, David Brici, ... Rebecca M. Nisbet in Acta Neuropathologica Communications
    Article Open access 12 March 2021
  15. A Mutant Variant of E2F4 Triggers Multifactorial Therapeutic Effects in 5xFAD Mice

    Alzheimer’s disease (AD) has a complex etiology, which requires a multifactorial approach for an efficient treatment. We have focused on E2 factor 4...

    Noelia López-Sánchez, Morgan Ramón-Landreau, ... José M. Frade in Molecular Neurobiology
    Article Open access 07 March 2022
  16. Melatonin ameliorates spatial memory and motor deficits via preserving the integrity of cortical and hippocampal dendritic spine morphology in mice with neurotrauma

    We aimed to elucidate the role of cortical and hippocampal dendritic spines on neurological deficits associated with hippocampal microgliosis,...

    **ao-**g Lin, Ruoxu Liu, ... Cheng-Hsien Lin in Inflammopharmacology
    Article 21 September 2020
  17. Neuron-Microglia Dynamic Duo in Chronic Abdominal Pain

    Abdominal pain is one of the main symptoms of chronic gastrointestinal disorders including inflammatory bowel diseases (IBD) and irritable bowel...
    Manon Defaye, Christophe Altier in Visceral Pain
    Chapter 2023
  18. Flavonoids: A Promising Neuroprotectant and Its Salutary Effects on Age-Related Neurodegenerative Disorders

    Neurodegenerative disorders have become one of the most serious threats to global civilization in recent years. According to present data and future...
    Sanjib Kumar Das, Koushik Sen, ... Nithar Ranjan Madhu in Neuroprotective Effects of Phytochemicals in Brain Ageing
    Chapter 2024
  19. Interleukin-6-elicited chronic neuroinflammation may decrease survival but is not sufficient to drive disease progression in a mouse model of Leigh syndrome

    Background

    Mitochondrial diseases (MDs) are genetic disorders characterized by dysfunctions in mitochondria. Clinical data suggest that additional...

    Kevin Aguilar, Carla Canal, ... Juan Hidalgo in Journal of Inflammation
    Article Open access 11 January 2024
  20. The APOE-R136S mutation protects against APOE4-driven Tau pathology, neurodegeneration and neuroinflammation

    Apolipoprotein E4 ( APOE4 ) is the strongest genetic risk factor for late-onset Alzheimer’s disease (LOAD), leading to earlier age of clinical onset...

    Maxine R. Nelson, Peng Liu, ... Yadong Huang in Nature Neuroscience
    Article Open access 13 November 2023
Did you find what you were looking for? Share feedback.